뒤로
Dri Healthcare Trust(DHTRF) 가격
DHTRF 주가 차트
DHTRF 수입
Dri Healthcare Trust
$11.48
0%
$0
종가: Jan 23, 16:00:00 GMT-5
$11.48
0%
$0
애프터마켓: Jan 23, 20:00:00 GMT-5
최신 수익 결과: Q3 '25
보고됨: 2025-11-05
역사적 수익
분기별
연간
EPS
수익
Earnings FAQ
DHTRF의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Dri Healthcare Trust DHTRF의 지난 분기 매출 실적은 어땠나요?
Dri Healthcare Trust의 매출 추정치는 얼마인가요?
Dri Healthcare Trust의 수익 품질 점수는 얼마인가요?
Dri Healthcare Trust는 언제 수익을 보고하나요?
Dri Healthcare Trust의 예상 수익은 얼마인가요?
Dri Healthcare Trust은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$11.48
시가
$11.48
일일 범위
$11.48 - $11.48
52주 범위
$7.54 - $13.02
거래량
100
평균 거래량
943
EPS(TTM)
0.07
배당수익률
--
시가총액
$632.6M
DHTRF란 무엇인가요?
DRI Healthcare Trust is an unincorporated open-ended company. The company is headquartered in Toronto, Ontario and currently employs 36 full-time employees. The company went IPO on 2021-02-11. The firm provides capital to universities and research institutions, academic institutions, biotechnology companies and pharmaceutical companies. The company has acquired more than 75 royalties on 45-plus drugs, including Ekterly, Eylea, Keytruda, Orserdu, Remicade, Spinraza, Stelara, Vonjo and Zytiga. Its portfolio includes Empaveli/Syfovre, Eylea I, Eylea II, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, and other products. Its therapeutic areas include oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, lysosomal storage disorders (LSD) and immunology. The Company’s products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; Vertex Pharmaceuticals; KalVista, Galderma and others.